MU
42
14
AON
25
4
AIV
39
6
SJM
17
5
HSIC
42
2
WFC
58
8
HES
49
2
EW
55
5
NTAP
58
3
HIG
48
5
XEL
48
11
FE
34
4
FOXA
67
5
IBM
53
2
SRE
37
9
FOX
71
3
WAT
55
11
CPB
24
2
JNPR
59
3
ADT
12
2
MU
42
14
AON
25
4
AIV
39
6
SJM
17
5
HSIC
42
2
WFC
58
8
HES
49
2
EW
55
5
NTAP
58
3
HIG
48
5
XEL
48
11
FE
34
4
FOXA
67
5
IBM
53
2
SRE
37
9
FOX
71
3
WAT
55
11
CPB
24
2
JNPR
59
3
ADT
12
2
Financhill
Back

Ensign Group 10K Form

Sell
46

ENSG
Ensign Group

Last Price:
$134.45
Seasonality Move:
2.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENSG News And Ratings

See the #1 stock for the next 7 days that we like better than ENSG

ENSG Financial Statistics

Sales & Book Value

Annual Sales: $3.7B
Cash Flow: $89M
Price / Cash Flow: 40.38
Annual Sales: $30.50
Price / Book: 4.41

Profitability

EPS (TTM): 4.12000
Net Income (TTM): $240M
Gross Margin: $590.8M
Return on Equity: 15.07%
Return on Assets: 5.55%

Ensign Group Earnings Forecast

Key Ensign Group Financial Ratios

  • The Gross Profit Margin over the past 22 years for ENSG is 15.84%.
  • The Selling, General & Administrative Expenses for ENSG have been equal to 7.05% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 3.86% of Operating Income.
  • The Net Earning history of ENSG is 5.61% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 15 years.

Ensign Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: ENSG
CUSIP: 29358P
Website: ensigngroup.net

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 1.56
Quick Ratio: 1.46

Price-to-Earnings

Trailing P/E Ratio: 36.84
Forward P/E Ratio: 21.87

ENSG Technical Analysis vs Fundamental Analysis

Sell
46
Ensign Group (ENSG) is a Sell

Is Ensign Group a Buy or a Sell?

  • Ensign Group stock is rated a Sell
    The current Ensign Group [ENSG] share price is $134.47. The Score for ENSG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.